Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis:: The role of Helicobacter pylori infection and portal hypertensive gastropathy

被引:20
作者
Dore, MP [1 ]
Mura, D [1 ]
Deledda, S [1 ]
Maragkoudakis, E [1 ]
Pironti, A [1 ]
Realdi, G [1 ]
机构
[1] Univ Sassari, Ist Clin Med, I-07100 Sassari, Italy
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 18卷 / 08期
关键词
cirrhosis; congestive gastropathy; Helicobacter pylori infection; portal hypertension;
D O I
10.1155/2004/150674
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIM: The relationship between Helicobacter pylori infection and peptic ulcer disease in cirrhosis remains controversial. The purpose of the present Study was to investigate the role of H pylori infection and portal hypertension gastropathy in the prevalence of active peptic ulcer among dyspeptic patients with compensated hepatitis C virus (HCV)-related cirrhosis. METHODS: Patients undergoing upper endoscopy with compensated HCV-related cirrhosis were enrolled. Child-Pugh's score was deter, mined at the entry. Variceal size was measured endoscopically and the severity of portal hypertensive gastropathy was graded. H pylori infection status was determined by urea breath testing and/or histology. RESULTS: A total of 178 patients positive for HCV (A and B Child-Pugh's score) were prospectively included. The prevalence of H pylori infection was 43%. An active peptic ulcer was found in 14 patients (8%) and was significantly more common among those with H pylori infection (16% versus 2% in H pylori uninfected patients, odds ratio: 8.0). No association was observed between H pylori infection and variceal size, or hypertensive gastropathy. CONCLUSIONS: Patients with compensated cirrhosis and H pylori infection showed higher risk of developing a peptic ulcer. Clinical relevance of this result would be that dyspeptic patients with HCV-related cirrhosis may benefit from preventive screening and eradication of H pylori, especially those with features of insufficient hemostasis.
引用
收藏
页码:521 / 524
页数:4
相关论文
共 24 条
[1]
Bahnacy A, 1996, Helicobacter, V1, P168, DOI 10.1111/j.1523-5378.1996.tb00033.x
[2]
Balan KK, 1996, AM J GASTROENTEROL, V91, P1400
[3]
BONNEVIE O, 1977, GASTROENTEROLOGY, V73, P1000
[4]
Calvet X, 1998, AM J GASTROENTEROL, V93, P2501, DOI 10.1111/j.1572-0241.1998.00711.x
[5]
ROLE OF HELICOBACTER-PYLORI IN CIRRHOTIC-PATIENTS WITH PEPTIC-ULCER - A SEROLOGICAL STUDY [J].
CHEN, JJ ;
CHANGCHIEN, CS ;
TAI, DI ;
CHIOU, SS ;
LEE, CM ;
KUO, CH .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) :1565-1568
[6]
DAGRADI AE, 1970, AM J GASTROENTEROL, V54, P458
[7]
NATURAL-HISTORY OF CONGESTIVE GASTROPATHY IN CIRRHOSIS [J].
DAMICO, G ;
MONTALBANO, L ;
TRAINA, M ;
PISA, R ;
MENOZZI, M ;
SPANO, C ;
PAGLIARO, L .
GASTROENTEROLOGY, 1990, 99 (06) :1558-1564
[8]
DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983
[9]
Novel monoclonal antibody-based Helicobacter pylori stool antigen test [J].
Dore, MP ;
Negrini, R ;
Tadeu, V ;
Marras, L ;
Maragkoudakis, E ;
Nieddu, S ;
Simula, L ;
Cherchi, GB ;
Massarelli, G ;
Realdi, G .
HELICOBACTER, 2004, 9 (03) :228-232
[10]
Dore MP, 1998, ALIMENT PHARM THER, V12, P635